Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
306 | 3 | INTEGRIN//OSTEOPONTIN//MATRIX METALLOPROTEINASE | 40954 |
587 | 2 | INTEGRIN//FOCAL ADHESION KINASE//TENASCIN C | 14663 |
4922 | 1 | INTEGRIN ALPHAVBETA3//CILENGITIDE//RGD PEPTIDE | 1730 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | INTEGRIN ALPHAVBETA3 | authKW | 857764 | 5% | 52% | 90 |
2 | CILENGITIDE | authKW | 626388 | 3% | 72% | 48 |
3 | RGD PEPTIDE | authKW | 442263 | 7% | 21% | 116 |
4 | ALPHAVBETA3 | authKW | 361002 | 2% | 47% | 42 |
5 | MED ISOTOPES | address | 314824 | 3% | 39% | 44 |
6 | INTEGRIN | authKW | 293297 | 21% | 4% | 361 |
7 | RGD | authKW | 273699 | 6% | 15% | 102 |
8 | TC 99M 3PRGD2 | authKW | 256162 | 1% | 94% | 15 |
9 | ALPHAVBETA3 INTEGRIN | authKW | 237455 | 2% | 35% | 37 |
10 | INTETUMUMAB | authKW | 116580 | 0% | 80% | 8 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 3208 | 13% | 0% | 230 |
2 | Radiology, Nuclear Medicine & Medical Imaging | 3183 | 17% | 0% | 302 |
3 | Oncology | 2724 | 22% | 0% | 381 |
4 | Chemistry, Organic | 819 | 11% | 0% | 194 |
5 | Medicine, Research & Experimental | 684 | 9% | 0% | 148 |
6 | Pharmacology & Pharmacy | 548 | 13% | 0% | 220 |
7 | Biochemistry & Molecular Biology | 468 | 18% | 0% | 305 |
8 | Biochemical Research Methods | 436 | 6% | 0% | 107 |
9 | Cell Biology | 328 | 9% | 0% | 156 |
10 | Chemistry, Multidisciplinary | 115 | 8% | 0% | 146 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MED ISOTOPES | 314824 | 3% | 39% | 44 |
2 | INTERDIPARTIMENTALE STUDI BIOMOL PLICAZ I | 91080 | 0% | 100% | 5 |
3 | INTER PRECLIN DEV MOL IMAGING CISPIM | 81969 | 0% | 75% | 6 |
4 | CISPIM | 72864 | 0% | 100% | 4 |
5 | ONCOL PLATFORM | 72864 | 0% | 100% | 4 |
6 | MOL IMAGING NANOMED | 62147 | 2% | 13% | 26 |
7 | RADIOL MIPS | 58290 | 0% | 80% | 4 |
8 | BONE BIOL OSTEOPOROSIS | 53205 | 1% | 19% | 15 |
9 | RADIOL BIOX | 48574 | 0% | 67% | 4 |
10 | MIPS | 43707 | 2% | 8% | 31 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | THERANOSTICS | 12889 | 1% | 3% | 25 |
2 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 11422 | 3% | 1% | 46 |
3 | MOLECULAR IMAGING | 11216 | 1% | 4% | 17 |
4 | MOLECULAR IMAGING AND BIOLOGY | 11015 | 1% | 2% | 25 |
5 | BIOCONJUGATE CHEMISTRY | 9795 | 3% | 1% | 53 |
6 | JOURNAL OF NUCLEAR MEDICINE | 6709 | 4% | 1% | 62 |
7 | NUCLEAR MEDICINE AND BIOLOGY | 5931 | 2% | 1% | 35 |
8 | CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 5922 | 1% | 1% | 22 |
9 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 3169 | 4% | 0% | 68 |
10 | MOLECULAR PHARMACEUTICS | 2135 | 1% | 1% | 20 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTEGRIN ALPHAVBETA3 | 857764 | 5% | 52% | 90 | Search INTEGRIN+ALPHAVBETA3 | Search INTEGRIN+ALPHAVBETA3 |
2 | CILENGITIDE | 626388 | 3% | 72% | 48 | Search CILENGITIDE | Search CILENGITIDE |
3 | RGD PEPTIDE | 442263 | 7% | 21% | 116 | Search RGD+PEPTIDE | Search RGD+PEPTIDE |
4 | ALPHAVBETA3 | 361002 | 2% | 47% | 42 | Search ALPHAVBETA3 | Search ALPHAVBETA3 |
5 | INTEGRIN | 293297 | 21% | 4% | 361 | Search INTEGRIN | Search INTEGRIN |
6 | RGD | 273699 | 6% | 15% | 102 | Search RGD | Search RGD |
7 | TC 99M 3PRGD2 | 256162 | 1% | 94% | 15 | Search TC+99M+3PRGD2 | Search TC+99M+3PRGD2 |
8 | ALPHAVBETA3 INTEGRIN | 237455 | 2% | 35% | 37 | Search ALPHAVBETA3+INTEGRIN | Search ALPHAVBETA3+INTEGRIN |
9 | INTETUMUMAB | 116580 | 0% | 80% | 8 | Search INTETUMUMAB | Search INTETUMUMAB |
10 | F 18 GALACTO RGD | 109296 | 0% | 100% | 6 | Search F+18+GALACTO+RGD | Search F+18+GALACTO+RGD |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |